Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Peter Crow (NPI 1740233816)

Field	Value
Entity Type	Individual
Organization	Peter Crow
Address	200 Technology Dr
City	Hooksett
State	NH
ZIP	03106
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 18, 2006

Payer Source	Total Paid
Medicare	$415.1K
Medicaid	$0

Key Findings

PETER CROW is a Hematology & Oncology Physician with an NPI enumerated on 2006-05-18 (~20 years ago), and his lifetime Medicare revenue on file is $415.1K while Medicaid billing is listed as none. This tenure and single-payer footprint suggest an established, Medicare-focused oncology practice rather than a cross‑payor safety‑net provider or Medicaid-heavy clinic.

Revenue for this provider is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 86.2% of this provider's total Medicare revenue. The single largest driver is J9271 (J9271 – Injection, pembrolizumab, 1 mg) with 6.6K claims, $43 avg paid/claim, $283.8K revenue (68.4% of this provider's total Medicare revenue), indicating that most Medicare dollars for this provider are tied to a single high-cost immunotherapy agent.

The code mix is consistent with an oncology infusion practice: chemotherapy administration codes appear among the top billings (96413 with 192 claims, $107 avg paid/claim, $20.5K revenue (5.0%); 96417 with 44 claims, $53 avg paid/claim, $2.3K revenue (0.6%); and 96415 with 55 claims, $23 avg paid/claim, $1.3K revenue (0.3%)). These administration and add-on codes, together with the dominant J9271 drug billing, point to routine outpatient infusion sessions supported by procedural chemotherapy workflows rather than a primarily diagnostic or surgical specialty.

Payer mix is effectively single-payer: Medicare accounts for the entire billing footprint captured here ($415.1K) while Medicaid is reported as none, indicating little to no Medicaid revenue exposure. For analysts, this implies revenue sensitivity to Medicare policy, reimbursement changes for injected oncology drugs, and utilization shifts in the Medicare population rather than state Medicaid dynamics.

Competitive standing by code shows mixed positioning: J9271, despite producing $283.8K (68.4% of Medicare revenue), ranks #1566 of 1841 providers nationally (14th percentile; typical, unremarkable volume for this code), so this provider is not a top national dispenser of pembrolizumab even though it relies on it for most revenue. By contrast, office E/M volumes are comparatively strong: 99214 (515 claims, $91 avg paid/claim, $46.9K revenue (11.3%)) ranks #46607 of 479517 (90th percentile; typical, unremarkable volume) and 99213 (458 claims, $59 avg paid/claim, $27K revenue (6.5%)) ranks #31470 of 457151 (93th percentile; typical, unremarkable volume), indicating above-typical outpatient visit activity relative to national peers.

Operationally, the provider reports substantial E/M visit counts that support ongoing management of oncology patients: 99214 at 515 claims and 99213 at 458 claims, together accounting for a meaningful share of non-drug Medicare revenue. This visit pattern aligns with repeated follow-up and management encounters typical of longitudinal oncology care and suggests clinic capacity for both infusion and office-based management.

From a risk and business-readiness perspective, the practice’s heavy dependence on a single drug code (J9271 contributing 68.4% of Medicare revenue and the top three codes contributing 86.2%) creates concentration risk: changes in utilization, coverage, or reimbursement for pembrolizumab could materially affect practice revenue. Coupled with the absence of Medicaid billing (none), the provider has limited payer diversification, so analysts should prioritize monitoring Medicare drug reimbursement and utilization trends when forecasting revenue or assessing competitive threats.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	6,600	$40	$283.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	520	$90	$46.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	460	$60	$27K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	190	$110	$20.5K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	100	$130	$12.8K
99233	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	40	$90	$3.7K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	20	$160	$3.3K
99232	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	50	$60	$3K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	110	$20	$2.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	20	$130	$2.5K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

Peter Crow — 1 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	6	10	10,000	$40	$440.2K
96413	8	20	140	$100	$15.8K
99214	197	3,150	110	$80	$13.2K
99233	389	600	70	$90	$10.9K
99232	604	990	70	$60	$9.8K
99223	577	700	30	$130	$7.2K
99213	121	2,900	70	$50	$6.9K
99215	183	1,080	40	$110	$6.8K
99205	257	440	20	$140	$4.9K
99204	977	1,340	30	$100	$4.6K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Peter Crow, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Elliot Professional Services	NH	Internal Medicine Physician	$0	$12.8M
Maxwell Elia	NH	Ophthalmology Physician	$2.3M	$0
Ahad Fazelat	NH	Ophthalmology Physician	$2.1M	$0
Anthony Correnti	NH	Ophthalmology Physician	$1.5M	$0
Gina Divenuti	NH	Hematology & Oncology Physician	$1M	$0
Frederick Briccetti	NH	Hematology & Oncology Physician	$861.3K	$0
Josy Mathew	NH	Hematology & Oncology Physician	$452.4K	$0
Anthony Squillaro	NJ	Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician	$415.6K	$0
Michael Buff	NH	Hematology & Oncology Physician	$387.2K	$0
Kimberly Licciardi	NH	Ophthalmology Physician	$331.8K	$0

Nearby Providers

Other providers in the same ZIP code as Peter Crow, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Neurodevelopmental Institute Of New Hampshire, LLC	NH	Clinical Neuropsychologist	$0	$4.2M
Herron & Smith, LLC	NH	Durable Medical Equipment & Medical Supplies	$0	$2.6M
Sunshine Community Care Inc.	NH	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$2.5M
Maintaining Independence Adult Day Services, Inc.	NH	Adult Day Care Clinic/Center	$0	$477.5K
Town Of Hooksett	NH	Ambulance	$182.5K	$176.2K
New Hampshire Adult Day Care	NH	Adult Day Care Clinic/Center	$0	$349K
Hooksett Special Education	NH	Local Education Agency (LEA)	$0	$292.9K
Alison Loranger	NH	Optometrist	$197.8K	$0
Cvs Manchester Nh, L.L.C.	NH	Pharmacy	$143K	$0
Walgreen Co	NH	Pharmacy	$132.4K	$0

Peter Crow — Billing Profile & Reimbursement Data

Sign up for Peter Crow — Billing Profile & Reimbursement Data policy alerts

Peter Crow — Billing Profile & Reimbursement Data

Sign up for Peter Crow — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References